[Effect of glucosylceramide synthase on P-gp expression by ERK signal transduction pathway in leukemia multi-drug resistance cell line]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Jun;29(3):270-4. doi: 10.3760/cma.j.issn.1003-9406.2012.03.005.
[Article in Chinese]

Abstract

Objective: To investigate the effect of glucosylceramide synthase (GCS) on P-glycoprotein (P-gp) expression via extracellular signal-regulated kinase (ERK) pathways in leukemia K562/A02 cell line.

Methods: K562/A02 multidrug resistance cells were treated with GCS siRNA and U0126, respectively. Expression of multidrug resistance protein 1 (MDR1) mRNA was analyzed with qRT-PCR. Phosphorylated ERK1/2, total ERK1/2 protein and P-gp in different groups were measured with Western blotting.

Results: After treated with U0126, P-ERK1/2 was decreased along with the increased U0126 concentration. P-ERK1/2 and P-gp were apparently down-regulated by U0126 at the concentrations of 20 μmol/L, 40 μmol/L and 60 μmol/L. After being transfected with GCS siRNA, GCS mRNA was inhibited by 70.50% (58.00%-76.00%) in K562/A02 cells. Compared with the negative control, both P-ERK1/2 and P-gp were inhibited significantly after RNAi for 72 hours (P<0.01 and P<0.05, respectively.

Conclusion: GCS may affect the expression of P-gp by ERK signal transduction pathway in leukemia cells.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / biosynthesis*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Cell Line, Tumor
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Glucosyltransferases / metabolism*
  • Humans
  • K562 Cells
  • Leukemia / enzymology
  • Leukemia / genetics
  • Leukemia / metabolism*
  • MAP Kinase Signaling System*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Glucosyltransferases
  • ceramide glucosyltransferase